H&Q HEALTHCARE INVESTORS (HQH) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 43 transactions totaling $1.7M, demonstrating a bullish sentiment with $1.7M in net insider flow. The most recent transaction on Jul 16, 2024 involved a purchase of 1,000 shares valued at $18.9K.
No significant insider buying has been recorded for HQH in the recent period.
No significant insider selling has been recorded for HQH in the recent period.
Based on recent SEC filings, insider sentiment for HQH is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at H&Q HEALTHCARE INVESTORS (HQH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading HQH stock, having executed 43 transactions in the past 90 days. The most active insider is Daniel R. Omstead (Executive), who has made 19 transactions totaling $1.7M.
Get notified when executives and directors at HQH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 16, 2024 | Dimartino Rose | Executive | Purchase | 1,000 | $18.88 | $18.9K | |
| Apr 9, 2024 | Goetz Kathleen | Executive | Purchase | 525 | $16.42 | $8.6K | |
| Jan 2, 2024 | Reit Todd | Executive | Purchase | 1,000 | $16.93 | $16.9K | |
| Dec 28, 2023 | Maher Bill | Executive | Purchase | 1,000 | $16.58 | $16.6K | |
| Dec 21, 2023 | R. Goodson Alan | Executive | Purchase | 170 | $16.13 | $2.7K | |
| Sep 25, 2023 | R. Omstead Daniel | Executive | Purchase | 9,500 | $15.63 | $148.5K | |
| Sep 20, 2023 | R. Omstead Daniel | Executive | Purchase | 9,500 | $15.88 | $150.9K | |
| Mar 23, 2022 | Goetz Kathleen | Executive | Purchase | 73.53 | $20.42 | $1.5K | |
| Jan 26, 2022 | Goetz Kathleen | Executive | Purchase | 481 | $21.52 | $10.4K | |
| Oct 26, 2020 | R. Omstead Daniel | Executive | Purchase | 5,200 | $20.53 | $106.8K | |
| Oct 21, 2020 | R. Omstead Daniel | Executive | Purchase | 5,050 | $20.68 | $104.4K | |
| Sep 23, 2020 | Allen Bailey Jeffrey | Executive | Purchase | 490 | $20.39 | $10.0K | |
| May 21, 2020 | R. Omstead Daniel | Executive | Purchase | 5,000 | $21.01 | $105.0K | |
| Mar 17, 2020 | R. Omstead Daniel | Executive | Purchase | 6,800 | $16.24 | $110.4K | |
| Dec 26, 2018 | R. Omstead Daniel | Executive | Purchase | 6,300 | $17.14 | $108.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 37 | $1.7M | 80.6% |
Exercise (Options)(X) | 6 | $400.9K | 19.4% |
Insiders at H&Q HEALTHCARE INVESTORS are accumulating shares at an accelerated pace. With 14 insiders making 43 transactions totaling $1.7M in purchases versus $0 in sales, the net buying activity of $1.7M signals strong executive confidence. Daniel R. Omstead (Executive) leads the buying activity with $1.7M in transactions across all time.